Characterization of LoKe demonstrated that tumor cells harbor an Rb gene deletion that compensates for the oncogenic function of MCV LT expression in MCC (Houben et al., 2012; Hesbacher et al., 2016). This evidence concerns the gene RB1 and neoplasm.